What is the annual percentage growth rate of cancer in India?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cancer Growth Rate in India

The annual percentage increase in cancer incidence in India is approximately 0.9-1.2% based on recent national registry data, with the total cancer burden projected to increase by 12.8% from 2020 to 2025. 1

Current Cancer Burden Statistics

The cancer landscape in India shows significant growth patterns:

  • Total incident cases in 2022: 1,461,427 cases (crude rate: 100.4 per 100,000 population) 1
  • Projected cases for 2025: Expected to increase by 12.8% compared to 2020 baseline 1
  • Lifetime risk: One in nine people in India will develop cancer during their lifetime 1

Temporal Trends in Cancer Incidence

The age-standardized incidence rate has shown variable patterns across different cancer types from 1990 to 2016:

  • Increasing cancers: Breast cancer incidence increased by 40.7% (95% UI 7.0-85.6) over this 26-year period 2
  • Decreasing cancers: Stomach cancer decreased by 39.7%, cervical cancer by 39.7%, esophageal cancer by 31.2%, lip and oral cavity cancer by 6.4%, and leukemia by 16.1% 2
  • Overall trend: While absolute numbers are rising due to population growth and aging, the age-standardized incidence rate has not changed substantially from 1990 to 2016 2

Regional Variation in Cancer Growth

Cancer incidence shows marked geographic heterogeneity:

  • Highest incidence districts: Aizawl district (269.4 per 100,000 in males) and Papumpare district (219.8 per 100,000 in females) 3
  • Fastest growing region: Kamrup urban showed the highest annual percentage change of 3.8% (P < .05) 3
  • State-level variation: The age-standardized cancer DALY rate varied 2.6-fold across Indian states in 2016 2

Leading Cancer Sites Contributing to Growth

The five most common cancers projected for 2020-2025 are:

  1. Breast cancer (10.5% of total cancer burden) - showing significant upward trend 4, 2
  2. Lung cancer (10.6% of total burden) 4
  3. Mouth cancer (5.7% of total burden) 4
  4. Cervix uteri (5.2% of burden) - showing downward trend in incidence 4, 2
  5. Tongue cancer 3

Projected Future Burden

The cancer burden measured in DALYs demonstrates substantial growth:

  • 2021 projection: 26.7 million DALYs 4
  • 2025 projection: 29.8 million DALYs (11.6% increase over 4 years) 4
  • Absolute case projection: 1,392,179 incident cases expected in 2020 3

Key Drivers of Cancer Growth

Several factors contribute to the increasing cancer burden:

  • Population aging: The proportion of cancer deaths increased from 4.15% in 1990 to 8.3% in 2016, doubling the contribution of cancer to total mortality 2
  • Tobacco use: Remains the leading risk factor, attributable to 10.9% of cancer DALYs in 2016 2
  • Late-stage presentation: Approximately 50% of patients present with locally advanced disease, limiting treatment effectiveness 5
  • Changing risk factor profiles: Increasing obesity prevalence and decreasing physical activity contribute to rising incidence of certain cancers 6

Important Caveats

The growth rate estimates have limitations:

  • Cancer is not a notifiable disease in India, leading to potential underestimation of true incidence rates 5
  • Data quality varies significantly between urban and rural areas, where 70% of the population resides with limited cancer registry coverage 5
  • The 12.8% projected increase from 2020 to 2025 reflects both true incidence growth and improved detection/reporting systems 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.